Biotech Growth Trust swaps out Celgene and Alexion for Amgen OrbiMed, the manager of the UK’s Biotech Growth Trust BIOG, has boosted the trust’s investment in Amgen at the expense of previous long-term holdings in Celgene and Alexion over the last month, according to the November portfolio update. Amgen is now the trust’s joint second largest investment (at 10% […]
Aberdeen Private Equity bites the dust – Following consultation with Aberdeen Private Equity’s largest shareholders and an extensive process to identify potential purchasers, the board has announced that the company has entered into a sale and purchase agreement (the “SPA”) to sell its entire investment portfolio at a modest premium to its 31 October 2017 […]
US analysts target key Woodford Patient Capital investees The Neil Woodford-managed biotech/tech investment trust, Woodford Patient Capital Trust (WPCT), is finding itself under increasing pressure, with analysts at two separate US firms calling into question its two largest investments, Prothena (15.6% of NAV at 30 September ) and Oxford Nanopore (8.9%). Ireland-based but Nasdaq-listed Prothena […]
Ranger slashes NAV again – Ranger Direct Lending has announced that it will make a further provision against Princeton/Argon and this will amount to a hit of about 3.8% to the end September NAV. The full text follows: “Further to the Company’s announcements regarding the bankruptcy proceedings in respect of Argon Credit, LLC and Argon X, […]
Lowland extends its run of above average dividend increases – Lowland’s NAV total return was 17.0% for the year ended 30 September 2017, compared with the benchmark All-Share Index return of 11.9%. Three interim dividends of 12.0p have been paid and a final dividend of 13.0p is proposed, total dividends for the year will amount to […]
EP Special Opportunities dives on Luceco profit warning – EP Special Opportunities’ shares are 23.3% lower at lunchtime today (15 December) following a profit warning from its largest investment. Luceco profit warning Luceco made the following announcement this morning “Luceco plc, the manufacturer and distributor of high quality and innovative LED lighting products, wiring accessories […]
Primary Healthcare Properties investing in Cork – Primary Health Properties ICAV, an Irish investment vehicle wholly owned by Primary Healthcare Properties, has agreed to acquire a large modern primary heathcare facility in County Cork, Ireland for a total cost of €20 million. The facility comprises a lettable area of circa 6,500m2 and will be fully let. […]
F&C Commercial Property buys Bristol office – F&C Commercial Property Holdings Limited, a subsidiary of F&C Commercial Property, has purchased a 56,059 sq ft prime office, One Cathedral Square, in Bristol for GBP33.5 million, reflecting a net initial yield of 5.0 per cent. The property is fully let to the strong covenants of the University of […]
3i Infrastructure gets bid for Elenia – In a statement released on 12 December, 3i Infrastructure said “Further to recent speculation, the board of 3i Infrastructure plc confirms that bids have been received from potential acquirers of Elenia. These bids are currently being considered by the company and the other shareholders in Elenia. The company […]
UK CAR-T firm Autolus provides update at ASH conference Autolus, which is a closely-watched chimeric antigen receptor T-cell therapy firm backed by three of the UK’s most prominent biotech investors, obtained an important validation of its technology recently with the publication of data on its dual targeting technology at the American Society of Hematology (ASH) conference over […]
